Related Experiment Video
Updated: May 14, 2026
09:43
Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons
Published on: May 25, 2015
Phrenic nerve conduction studies in patients with chronic obstructive pulmonary disease
Simon Podnar1, Matevž Harlander
1Institute of Clinical Neurophysiology, Division of Neurology, University Medical Center, SI-1525 Ljubljana, Slovenia. simon.podnar@kclj.si
Muscle & Nerve
|February 6, 2013
Summary
Reduced phrenic nerve compound motor action potential (CMAP) amplitude in hypercapnic respiratory failure suggests a neuromuscular disorder, not chronic obstructive pulmonary disease (COPD). This finding aids in diagnosing diaphragm dysfunction.
Area of Science:
- Neurology
- Pulmonology
- Respiratory Physiology
Background:
- Hypercapnic respiratory failure commonly stems from chronic obstructive pulmonary disease (COPD), but neuromuscular disorders are also key differentials.
- Phrenic nerve compound motor action potential (CMAP) amplitude reduction is investigated as a diagnostic marker.
Purpose of the Study:
- To determine the specificity of reduced phrenic nerve CMAP amplitude in diagnosing neuromuscular disorders in patients with hypercapnic respiratory failure.
- To differentiate diaphragm dysfunction due to neuromuscular causes from COPD.
Main Methods:
- Prospective recruitment of patients with advanced COPD and healthy controls.
- Bilateral phrenic nerve CMAPs measured via supraclavicular stimulation and bipolar recording.
Main Results:
- 20 COPD patients and 29 controls were analyzed.
- COPD patients exhibited significantly longer latency and higher amplitude phrenic nerve CMAPs compared to controls.
Conclusions:
- Reduced phrenic nerve CMAP amplitude in hypercapnic respiratory failure strongly indicates a neuromuscular disorder affecting the diaphragm.
- This diagnostic criterion helps distinguish neuromuscular causes from COPD or other lung disorders.
More Related Videos
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.